Biofil Chemicals & Pharmaceuticals Board of Directors

Get the latest insights into the leadership at Biofil Chemicals & Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Ramesh Shah Chairman & Managing Director
Mr. Ketan Shah Whole Time Director
Mr. Romil Shah Non Executive Director
Mrs. Gayatri Padiyar Independent Director
Mr. Ashok Kumar Ramawat Independent Director
Mr. Satish Beohar Independent Director

Biofil Chemicals & Pharmaceuticals Share price

BIOFILCHEM

43

0.37 (-0.85%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:25 IST
BUYSELL
Today's High

44.44

Today's Low

42.52

52 Week Low

40.40

52 Week High

91.87

The current prices are delayed, login to your account for live prices

Biofil Chemicals & Pharmaceuticals FAQs

The board at Biofil Chemicals & Pharmaceuticals consists of experienced professionals, including Mr. Ramesh Shah , Mr. Ketan Shah , and others, overseeing the company’s strategic and corporate governance.

Directors at Biofil Chemicals & Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Ramesh Shah is the current chairman at Biofil Chemicals & Pharmaceuticals.

Executive directors at Biofil Chemicals & Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Biofil Chemicals & Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Biofil Chemicals & Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.